Comments to OIRA: Priorities for Regulatory Cooperation for the North American OTC Industry

Share page:

Consumer Health Products Canada (CHP Canada) and the Consumer Healthcare Products Association (CHPA) respectfully submit this brief to the Office of Information and Regulatory Affairs (OIRA) within the Office of Management and Budget in response to the US-Canada Regulatory Cooperation Council (RCC) Request for Information issued October 9th 2018 (83 FR 50689).

Issues:

Related Posts

CHPA Welcomes New Board Members at June Meeting